Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Tucci

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Annals of Clinical and Laboratory Science|September 1, 1991
A direct current plasma emission spectrometric procedure for the assay of silicon in urineJ F Belliveau, W C Griffiths, C G Wright, et al.
The American Journal of Medicine|November 1, 1996
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosisJ R Tucci, R P Tonino, R D Emkey, et al.
Nature Genetics|June 1, 1997
Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21T A Mansfield, D B Simon, Z Farfel, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study CentersH G Bone, R W Downs, J R Tucci, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneE Siris, R S Weinstein, R Altman, et al.
Clinical Chemistry and Laboratory Medicine|May 15, 2001
Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone diseaseM Sarno, L Sarno, D Baylink, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 1998
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter studyE S Siris, A A Chines, R D Altman, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Annals of Clinical and Laboratory Science|September 1, 1991
A direct current plasma emission spectrometric procedure for the assay of silicon in urineJ F Belliveau, W C Griffiths, C G Wright, et al.
The American Journal of Medicine|November 1, 1996
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosisJ R Tucci, R P Tonino, R D Emkey, et al.
Nature Genetics|June 1, 1997
Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21T A Mansfield, D B Simon, Z Farfel, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1997
Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study CentersH G Bone, R W Downs, J R Tucci, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneE Siris, R S Weinstein, R Altman, et al.
Clinical Chemistry and Laboratory Medicine|May 15, 2001
Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone diseaseM Sarno, L Sarno, D Baylink, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 17, 1998
Risedronate in the treatment of Paget's disease of bone: an open label, multicenter studyE S Siris, A A Chines, R D Altman, et al.
Pageof 5